Linda L. Neuman, M.D., M.B.A., has served as Vice President of Clinical Development at Nurix since May 2024. Dr. Neuman is trained as an internist, practiced medicine for 10 years prior to entering industry, and has more than 12 years of drug development experience in both oncology and rare disease. Prior to joining Nurix, she held senior positions in clinical development at Aeglea BioTherapeutics, Catalyst Biosciences, Adverum Biotechnologies, Sunesis Pharmaceuticals, Puma Biotechnology, and Onyx Pharmaceuticals. Dr. Neuman completed her internal medicine residency at St. Vincent’s Hospital in Indianapolis. She holds a B.S. in Biology from Southern Illinois University at Edwardsville, an M.B.A from Indiana Wesleyan University, and an M.D from Southern Illinois University.
'